Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements

Go back to Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements
Aethlon Medical, Inc. (NASDAQ: AEMD) Delayed: 2.17 -0.11 (4.82%)
Previous Close $2.28    52 Week High $9.09 
Open $2.24    52 Week Low $4.02 
Day High $2.35    P/E N/A 
Day Low $2.17    EPS $-0.05 
Volume 11,814,871